660 Shares in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Bought by Union Bancaire Privee UBP SA

Union Bancaire Privee UBP SA bought a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 660 shares of the company’s stock, valued at approximately $42,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of IHE. US Bancorp DE lifted its position in shares of iShares U.S. Pharmaceuticals ETF by 137.0% in the 3rd quarter. US Bancorp DE now owns 384 shares of the company’s stock worth $27,000 after purchasing an additional 222 shares during the period. Assetmark Inc. raised its stake in iShares U.S. Pharmaceuticals ETF by 100.0% during the third quarter. Assetmark Inc. now owns 432 shares of the company’s stock worth $31,000 after buying an additional 216 shares during the last quarter. Allworth Financial LP lifted its holdings in iShares U.S. Pharmaceuticals ETF by 9.4% in the third quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock valued at $131,000 after buying an additional 159 shares during the period. EP Wealth Advisors LLC bought a new stake in iShares U.S. Pharmaceuticals ETF during the third quarter valued at $157,000. Finally, Farther Finance Advisors LLC boosted its position in iShares U.S. Pharmaceuticals ETF by 97.1% during the third quarter. Farther Finance Advisors LLC now owns 2,482 shares of the company’s stock valued at $175,000 after acquiring an additional 1,223 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Up 1.2 %

IHE stock opened at $72.85 on Wednesday. The firm has a market cap of $735.79 million, a PE ratio of 6.49 and a beta of 0.58. The stock has a 50-day moving average price of $68.02 and a 200-day moving average price of $69.33. iShares U.S. Pharmaceuticals ETF has a 1-year low of $62.67 and a 1-year high of $72.94.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.